 | | | | France's vaccine pass will remain in place until hospitals are able to function normally without cancelling non-emergency procedures to make room for COVID patients in intensive care, Health Minister Olivier Veran said on Wednesday. | | | | | | Doctors Without Borders (MSF) is providing mental health care for COVID-19 patients, their families and also medical staff in two public hospitals in Venezuela to support the country's run-down health system. | | | | | | Some of the 1,000 U.S. diplomats and intelligence officers hit by a mysterious illness known as Havana Syndrome could have been targeted by electromagnetic energy pulses, according to a report to U.S. intelligence leaders released on Wednesday. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | | The U.S. health regulator said on Wednesday that it had approved the first generic version of AbbVie Inc's Restasis, a treatment used in increasing tear production in patients with dry-eye syndrome. | | | | | | Italy will soon announce a timetable to roll back its COVID-19 curbs, Prime Minister Mario Draghi said on Wednesday, as a surge in cases fuelled by the highly contagious Omicron variant started to slow. | | | | | | Novo Nordisk on Wednesday rejected allegations by a U.S. congressional investigative committee that it has engaged in manoeuvres to increase net prices on life-saving insulin in tandem with its competitors on the U.S. insulin market. | | | | | | Turkey has recorded 110,682 new COVID-19 infections in the space of 24 hours, its highest daily figure of the pandemic, health ministry data showed on Wednesday. | | | | | | Britain reported 534 deaths within 28-days of a positive COVID-19 test on Wednesday, the highest daily figure since late February 2021. | | | | | | McKesson Corp is expected to report strong earnings on Wednesday as an Omicron-driven surge in demand for COVID-19 vaccines and tests is likely to insulate the drug distributor from tepid sales of other medical products. | | | | | |
